Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Synthesis and synergistic studies of isatin based mixed ligand complexes as potential antifungal therapeutic agents.

Dar OA, Lone SA, Malik MA, Aqlan FM, Wani MY, Hashmi AA, Ahmad A.

Heliyon. 2019 Jul 17;5(7):e02055. doi: 10.1016/j.heliyon.2019.e02055. eCollection 2019 Jul.

2.

Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.

Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A.

Lancet. 2019 May 18;393(10185):2073-2084. doi: 10.1016/S0140-6736(19)30501-X. Review.

PMID:
31106753
3.

Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.

Malik MA, Raza MK, Dar OA, Amadudin, Abid M, Wani MY, Al-Bogami AS, Hashmi AA.

Bioorg Chem. 2019 Jun;87:773-782. doi: 10.1016/j.bioorg.2019.03.080. Epub 2019 Apr 4.

PMID:
30974300
4.

Teratogenicity and accumulation of triclosan in the early life stages of four food fish during the bioassay.

Dar OI, Sharma S, Singh K, Kaur A.

Ecotoxicol Environ Saf. 2019 Jul 30;176:346-354. doi: 10.1016/j.ecoenv.2019.03.102. Epub 2019 Apr 4.

PMID:
30954000
5.

Is the current surge in political and financial attention to One Health solidifying or splintering the movement?

Spencer J, McRobie E, Dar O, Rahman-Shepherd A, Hasan N, Hanefeld J, Khan M.

BMJ Glob Health. 2019 Feb 8;4(1):e001102. doi: 10.1136/bmjgh-2018-001102. eCollection 2019.

6.

In-situ modification of castor oil with divalent metal ions like Zn (II), Cu (II), Co (II) and Ba (II) and their comparative antioxidant study by in-vitro methods.

Talukdar MIA, Akram MK, Singh T, Malik MA, Dar OA, Hashmi AA.

Food Chem. 2019 Jun 30;284:213-218. doi: 10.1016/j.foodchem.2019.01.033. Epub 2019 Jan 16.

PMID:
30744848
7.

Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?

Bhatia T, Enoch J, Khan M, Mathewson S, Heymann D, Hayes R, Dar O.

PLoS Med. 2019 Feb 4;16(2):e1002735. doi: 10.1371/journal.pmed.1002735. eCollection 2019 Feb. Review.

8.

Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.

Malik MA, Lone SA, Gull P, Dar OA, Wani MY, Ahmad A, Hashmi AA.

Med Chem. 2019;15(6):648-658. doi: 10.2174/1573406415666181203115957.

PMID:
30501599
9.

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

10.

Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.

Malik MA, Dar OA, Gull P, Wani MY, Hashmi AA.

Medchemcomm. 2017 Dec 6;9(3):409-436. doi: 10.1039/c7md00526a. eCollection 2018 Mar 1. Review.

11.

A summary and appraisal of existing evidence of antimicrobial resistance in the Syrian conflict.

Abbara A, Rawson TM, Karah N, El-Amin W, Hatcher J, Tajaldin B, Dar O, Dewachi O, Abu Sitta G, Uhlin BE, Sparrow A.

Int J Infect Dis. 2018 Oct;75:26-33. doi: 10.1016/j.ijid.2018.06.010. Epub 2018 Jun 21. Review.

12.

The growth and strategic functioning of One Health networks: a systematic analysis.

Khan MS, Rothman-Ostrow P, Spencer J, Hasan N, Sabirovic M, Rahman-Shepherd A, Shaikh N, Heymann DL, Dar O.

Lancet Planet Health. 2018 Jun;2(6):e264-e273. doi: 10.1016/S2542-5196(18)30084-6.

13.

Antimicrobial resistance in the context of the Syrian conflict: Drivers before and after the onset of conflict and key recommendations.

Abbara A, Rawson TM, Karah N, El-Amin W, Hatcher J, Tajaldin B, Dar O, Dewachi O, Abu Sitta G, Uhlin BE, Sparrow A.

Int J Infect Dis. 2018 Aug;73:1-6. doi: 10.1016/j.ijid.2018.05.008. Epub 2018 May 21. Review.

14.

Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB".

Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A.

Int J Infect Dis. 2018 Mar;68:122-124. doi: 10.1016/j.ijid.2018.03.002. Epub 2018 Mar 22. No abstract available.

15.

Visualising emergency department capacity in an 'Emergency Department Capacity Clock': A novel tool to assess and communicate overcrowding and access block.

Dar O, Loubser J.

Emerg Med Australas. 2017 Oct;29(5):587-591. doi: 10.1111/1742-6723.12816. Epub 2017 Jun 1.

PMID:
28571105
16.

Design, synthesis and spectroscopic characterization of metal (II) complexes derived from a tetradentate macrocyclic ligand: Study on antimicrobial and antioxidant capacity of complexes.

Gull P, Malik MA, Dar OA, Hashmi AA.

Microb Pathog. 2017 Mar;104:212-216. doi: 10.1016/j.micpath.2017.01.036. Epub 2017 Jan 23.

PMID:
28126666
17.

Design, synthesis, characterization and antimicrobial/antioxidant activities of 1, 4-dicarbonyl-phenyl-dihydrazide based macrocyclic ligand and its Cu(II), Co(II) and Ni(II) complexes.

Gull P, Dar OA, Malik MA, Hashmi AA.

Microb Pathog. 2016 Nov;100:237-243. doi: 10.1016/j.micpath.2016.10.003. Epub 2016 Oct 7.

PMID:
27725279
18.

A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries.

Mendelson M, Dar OA, Hoffman SJ, Laxminarayan R, Mpundu MM, Røttingen JA.

Int J Infect Dis. 2016 Oct;51:70-72. doi: 10.1016/j.ijid.2016.09.016. Epub 2016 Sep 16. No abstract available.

19.

The annual Hajj pilgrimage-minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines.

Shafi S, Dar O, Khan M, Khan M, Azhar EI, McCloskey B, Zumla A, Petersen E.

Int J Infect Dis. 2016 Jun;47:79-82. doi: 10.1016/j.ijid.2016.06.013. Epub 2016 Jun 22.

20.

Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis.

Khan MS, Osei-Kofi A, Omar A, Kirkbride H, Kessel A, Abbara A, Heymann D, Zumla A, Dar O.

Lancet Infect Dis. 2016 Aug;16(8):e173-7. doi: 10.1016/S1473-3099(16)30134-7. Epub 2016 Jun 20.

PMID:
27339456
21.

What is the experience from previous mass gathering events? Lessons for Zika virus and the Olympics 2016.

Zumla A, McCloskey B, Bin Saeed AA, Dar O, Al Otabi B, Perlmann S, Gautret P, Roy N, Blumberg L, Azhar EI, Barbeschi M, Memish Z, Petersen E.

Int J Infect Dis. 2016 Jun;47:1-4. doi: 10.1016/j.ijid.2016.06.010. Epub 2016 Jun 15.

22.

Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.

Zumla A, Dar O, Kock R, Muturi M, Ntoumi F, Kaleebu P, Eusebio M, Mfinanga S, Bates M, Mwaba P, Ansumana R, Khan M, Alagaili AN, Cotten M, Azhar EI, Maeurer M, Ippolito G, Petersen E.

Int J Infect Dis. 2016 Jun;47:5-9. doi: 10.1016/j.ijid.2016.06.012. Epub 2016 Jun 15.

23.

Communicable disease surveillance and control in the context of conflict and mass displacement in Syria.

Ismail SA, Abbara A, Collin SM, Orcutt M, Coutts AP, Maziak W, Sahloul Z, Dar O, Corrah T, Fouad FM.

Int J Infect Dis. 2016 Jun;47:15-22. doi: 10.1016/j.ijid.2016.05.011. Epub 2016 May 18. Review.

24.

Reducing risks to health and wellbeing at mass gatherings: the role of the Sendai Framework for Disaster Risk Reduction.

Aitsi-Selmi A, Murray V, Heymann D, McCloskey B, Azhar EI, Petersen E, Zumla A, Dar O.

Int J Infect Dis. 2016 Jun;47:101-4. doi: 10.1016/j.ijid.2016.04.006. Epub 2016 Apr 7. Review.

25.

Non-randomised Ebola trials--lessons for optimal outbreak research.

Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Puro V, Wölfel R, Avsic-Zupanc T, Ioannidis JP, Portella G, Kremsner P, Dar O, Bates M, Zumla A.

Lancet Infect Dis. 2016 Apr;16(4):407-8. doi: 10.1016/S1473-3099(16)00132-8. No abstract available.

PMID:
27036341
26.

Tuberculosis and mass gatherings-opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimage.

Zumla A, Saeed AB, Alotaibi B, Yezli S, Dar O, Bieh K, Bates M, Tayeb T, Mwaba P, Shafi S, McCloskey B, Petersen E, Azhar EI.

Int J Infect Dis. 2016 Jun;47:86-91. doi: 10.1016/j.ijid.2016.02.003. Epub 2016 Feb 9.

27.

Rapid Spread of Zika Virus in The Americas--Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games.

Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates M, Dar O, Mattes F, Kidd M, Ippolito G, Azhar EI, Zumla A.

Int J Infect Dis. 2016 Mar;44:11-5. doi: 10.1016/j.ijid.2016.02.001. Epub 2016 Feb 4. Review.

28.

Exploring the evidence base for national and regional policy interventions to combat resistance.

Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, Dar FK, Littmann J, Rweyemamu M, Buckley EJ, Shahid M, Kock R, Li HL, Giha H, Khan M, So AD, Bindayna KM, Kessel A, Pedersen HB, Permanand G, Zumla A, Røttingen JA, Heymann DL.

Lancet. 2016 Jan 16;387(10015):285-95. doi: 10.1016/S0140-6736(15)00520-6. Epub 2015 Nov 18. Review.

PMID:
26603921
29.

International cooperation to improve access to and sustain effectiveness of antimicrobials.

Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Smith R, Zorzet A, Cohn J, Pittet D, Daulaire N, Morel C, Rizvi Z, Balasegaram M, Dar OA, Heymann DL, Holmes AH, Moore LS, Laxminarayan R, Mendelson M, Røttingen JA.

Lancet. 2016 Jan 16;387(10015):296-307. doi: 10.1016/S0140-6736(15)00470-5. Epub 2015 Nov 18. Review.

PMID:
26603920
30.

Ebola: missed opportunities for Europe-Africa research.

Ippolito G, Lanini S, Brouqui P, Di Caro A, Vairo F, Abdulla S, Fusco FM, Krishna S, Capobianchi MR, Kyobe-Bosa H, Lewis DJ, Puro V, Wolfel R, Avsic-Zupanc T, Dar O, Mwaba P, Bates M, Heymann D, Zumla A.

Lancet Infect Dis. 2015 Nov;15(11):1254-5. doi: 10.1016/S1473-3099(15)00236-4. Epub 2015 Jul 28. No abstract available.

PMID:
26231479
31.

Keeping ahead of the resistance curve: product bundling to conserve artemisinin-based combination therapy.

Dar OA, Rokadiya S, Heymann DL.

Lancet Glob Health. 2015 Jun;3(6):e304-5. doi: 10.1016/S2214-109X(15)70018-5. Epub 2015 Apr 24. No abstract available.

32.

Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread.

McCloskey B, Dar O, Zumla A, Heymann DL.

Lancet Infect Dis. 2014 Oct;14(10):1001-10. doi: 10.1016/S1473-3099(14)70846-1. Epub 2014 Sep 1. Review.

PMID:
25189351
33.

Integrating health into disaster risk reduction strategies: key considerations for success.

Dar O, Buckley EJ, Rokadiya S, Huda Q, Abrahams J.

Am J Public Health. 2014 Oct;104(10):1811-6. doi: 10.2105/AJPH.2014.302134. Epub 2014 Aug 14.

34.

Medical abuse at Guantanamo Bay Military Prison--what do we do now?

Buckley EJ, Rokadiya S, Kessel A, Porter J, Dar O.

Trop Med Int Health. 2014 Sep;19(9):1000-2. doi: 10.1111/tmi.12348. Epub 2014 Jul 2. No abstract available.

35.

Emerging infectious diseases: opportunities at the human-animal-environment interface.

Dixon MA, Dar OA, Heymann DL.

Vet Rec. 2014 May 31;174(22):546-51. doi: 10.1136/vr.g3263. No abstract available.

PMID:
24920712
36.

Prevention is better than cure for emerging infectious diseases.

Heymann DL, Dar OA.

BMJ. 2014 Feb 21;348:g1499. doi: 10.1136/bmj.g1499. No abstract available.

37.

Hydatid cyst of urinary bladder.

Ganie FA, Dar OH, Kaleem A, Hassan S, Gani M.

Indian J Nephrol. 2013 Nov;23(6):462-3. doi: 10.4103/0971-4065.120348. No abstract available.

38.

Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake.

Dar O, Gobin M, Hogarth S, Lane C, Ramsay M.

J Public Health (Oxf). 2013 Sep;35(3):404-12. doi: 10.1093/pubmed/fdt052. Epub 2013 May 21.

PMID:
23695702
39.

Cardiac transplantation: who to refer and when.

Dar O, Banner NR.

Br J Hosp Med (Lond). 2013 May;74(5):258-63. No abstract available.

PMID:
23657020
40.

Tempering the risk: Rift Valley fever and bioterrorism.

Dar O, Hogarth S, McIntyre S.

Trop Med Int Health. 2013 Aug;18(8):1036-41. doi: 10.1111/tmi.12108. Epub 2013 Mar 26. No abstract available.

41.

Cell-to-cell variability analysis dissects the plasticity of signaling of common γ chain cytokines in T cells.

Cotari JW, Voisinne G, Dar OE, Karabacak V, Altan-Bonnet G.

Sci Signal. 2013 Mar 12;6(266):ra17. doi: 10.1126/scisignal.2003240.

42.

Rift Valley fever and a new paradigm of research and development for zoonotic disease control.

Dar O, McIntyre S, Hogarth S, Heymann D.

Emerg Infect Dis. 2013 Feb;19(2):189-93. doi: 10.3201/eid1902.120941.

43.

Conducting rapid health needs assessments in the cluster era: experience from the Pakistan flood.

Dar OA, Khan MS, Murray V.

Prehosp Disaster Med. 2011 Jun;26(3):212-6. doi: 10.1017/S1049023X11006261.

PMID:
22107774
44.

Millennium development goals and the water target: details, definitions and debate.

Dar OA, Khan MS.

Trop Med Int Health. 2011 May;16(5):540-4. doi: 10.1111/j.1365-3156.2011.02736.x. Epub 2011 Feb 14.

45.

Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11.

Ellis J, Galiano M, Pebody R, Lackenby A, Thompson C, Bermingham A, McLean E, Zhao H, Bolotin S, Dar O, Watson JM, Zambon M.

Euro Surveill. 2011 Jan 6;16(1). pii: 19760.

46.

Gedankenexperiment or just a flight of fancy?

Dar OA.

J Public Health (Oxf). 2009 Jun;31(2):293-5. doi: 10.1093/pubmed/fdp022. Epub 2009 Mar 22. No abstract available.

PMID:
19307191
47.

Judging respiratory specimen acceptability for AFB microscopy: visual vs. microscopic screening.

Khan MS, Dar O, Tahseen S, Godfrey-Faussett P.

Trop Med Int Health. 2009 May;14(5):571-5. doi: 10.1111/j.1365-3156.2009.02260.x. Epub 2009 Mar 2.

48.

A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study.

Dar O, Riley J, Chapman C, Dubrey SW, Morris S, Rosen SD, Roughton M, Cowie MR.

Eur J Heart Fail. 2009 Mar;11(3):319-25. doi: 10.1093/eurjhf/hfn050. Epub 2009 Jan 27.

49.

The role of apelin in cardiovascular function and heart failure.

Chandrasekaran B, Dar O, McDonagh T.

Eur J Heart Fail. 2008 Aug;10(8):725-32. doi: 10.1016/j.ejheart.2008.06.002. Epub 2008 Jun 25. Review.

Supplemental Content

Support Center